Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.30% | 151.85 | 0.0% | $2783.13m | |
| BNGO | BioNano Genomics, Inc. | -2.94% | 12.21 | 0.0% | $2518.37m | |
| GILD | Gilead Sciences, Inc. | -2.14% | 66.70 | 1.0% | $655.34m | |
| AMGN | Amgen, Inc. | 0.58% | 258.60 | 1.3% | $584.65m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.75% | 544.10 | 2.7% | $497.98m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.27% | 161.75 | 2.0% | $475.34m | |
| CRSP | CRISPR Therapeutics AG | -6.46% | 169.53 | 0.6% | $445.57m | |
| ILMN | Illumina, Inc. | -0.11% | 420.55 | 3.5% | $443.81m | |
| NVAX | Novavax, Inc. | -3.27% | 127.16 | 92.9% | $407.11m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.52% | 237.64 | 1.9% | $379.54m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.60% | 92.65 | 13.8% | $343.41m | |
| BIIB | Biogen, Inc. | -1.41% | 271.67 | 1.7% | $323.61m | |
| BNTX | BioNTech SE | -3.91% | 106.29 | 0.0% | $307.94m | |
| EXAS | EXACT Sciences Corp. | -8.37% | 141.04 | 19.6% | $251.66m | |
| PACB | Pacific Biosciences of California, Inc. | -8.54% | 32.88 | 7.4% | $199.92m |
Company Profile
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.